3 Biotech Stocks That Soared: Are They Buys?
Some of the biggest moves week in and week out come from biotech stocks. Whether it's a financial surprise, a positive clinical-trial update, regulatory approval, or even just rumors of potentially good news, biotech stocks can rise quickly.
Three biotech stocks did just that this past week, with gains of 18% to nearly 40%. Nektar Therapeutics (NASDAQ: NKTR), Wave Life Sciences (NASDAQ: WVE), and Savara soared over the past few days. Here's what lit a fire beneath these biotech stocks -- and whether they're buys after their huge gains.
Image source: Getty Images.
Source: Fool.com
Nektar Therapeutics Stock
€1.15
0.430%
Currently there is a rather positive sentiment for Nektar Therapeutics with 4 Buy predictions and 1 Sell predictions.
With a target price of 2 € there is a hugely positive potential of 73.31% for Nektar Therapeutics compared to the current price of 1.15 €.
